慢性活动性病灶：一种用于监测多发性硬化症治疗效果的新型磁共振成像生物标志物？ - Suppr

Suppr

超能文献

Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis?

作者信息

Preziosa Paolo, Filippi Massimo, Rocca Maria A

机构信息

Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Neurology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

出版信息

Expert Rev Neurother. 2021 Aug;21(8):837-841. doi: 10.1080/14737175.2021.1953983. Epub 2021 Jul 19.

DOI:10.1080/14737175.2021.1953983

PMID:34236010

Abstract

摘要

相似文献

Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis?

Expert Rev Neurother. 2021 Aug;21(8):837-841. doi: 10.1080/14737175.2021.1953983. Epub 2021 Jul 19.

Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.

Mult Scler. 2019 Dec;25(14):1915-1925. doi: 10.1177/1352458518814117. Epub 2018 Dec 19.

Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions.

AJNR Am J Neuroradiol. 2020 Sep;41(9):1584-1591. doi: 10.3174/ajnr.A6742. Epub 2020 Aug 20.

[A current view on the MRI diagnosis of multiple sclerosis: an update of 2016 revised MRI criteria].

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(2. Vyp. 2):66-73. doi: 10.17116/jnevro20171172266-73.

Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.

JAMA Neurol. 2019 Dec 1;76(12):1446-1456. doi: 10.1001/jamaneurol.2019.2478.

Imaging chronic active lesions in multiple sclerosis: a consensus statement.

Brain. 2024 Sep 3;147(9):2913-2933. doi: 10.1093/brain/awae013.

Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).

Eur Radiol. 2021 Feb;31(2):706-715. doi: 10.1007/s00330-020-07199-5. Epub 2020 Aug 26.

Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.

Brain. 2018 Sep 1;141(9):2605-2618. doi: 10.1093/brain/awy202.

Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple Sclerosis Severity.

AJNR Am J Neuroradiol. 2016 Aug;37(8):1447-53. doi: 10.3174/ajnr.A4726. Epub 2016 Mar 3.

MRI as an outcome in multiple sclerosis clinical trials.

Neurology. 2009 Feb 24;72(8):705-11. doi: 10.1212/01.wnl.0000336916.38629.43. Epub 2008 Dec 10.

引用本文的文献

Exploring factors driving the evolution of chronic lesions in multiple sclerosis using machine learning.

Eur Radiol. 2025 Jun 17. doi: 10.1007/s00330-025-11771-2.

T-Dark Rim as a Marker of New and Chronic Active Multiple Sclerosis Lesions: A Serial Study With Frequent 7T MRI.

J Neuroimaging. 2025 May-Jun;35(3):e70044. doi: 10.1111/jon.70044.

Towards a biological view of multiple sclerosis from early subtle to clinical progression: an expert opinion.

J Neurol. 2025 Feb 1;272(2):179. doi: 10.1007/s00415-025-12917-4.

Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance.

Ther Adv Neurol Disord. 2024 Dec 19;17:17562864241306684. doi: 10.1177/17562864241306684. eCollection 2024.

Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis.

Lancet Reg Health Eur. 2024 Aug 22;44:100978. doi: 10.1016/j.lanepe.2024.100978. eCollection 2024 Sep.

Gut-Brain Interactions and Their Impact on Astrocytes in the Context of Multiple Sclerosis and Beyond.

Cells. 2024 Mar 13;13(6):497. doi: 10.3390/cells13060497.

Astrocyte interferon-gamma signaling dampens inflammation during chronic central nervous system autoimmunity via PD-L1.

J Neuroinflammation. 2023 Oct 12;20(1):234. doi: 10.1186/s12974-023-02917-4.

Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid Biomarkers.

Neurotherapeutics. 2022 Jul;19(4):1216-1228. doi: 10.1007/s13311-022-01252-5. Epub 2022 Jun 6.

Predictive MRI Biomarkers in MS-A Critical Review.

Medicina (Kaunas). 2022 Mar 3;58(3):377. doi: 10.3390/medicina58030377.

Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression.

Neurol Neuroimmunol Neuroinflamm. 2022 Feb 1;9(2). doi: 10.1212/NXI.0000000000001139. Print 2022 Mar.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验